Peng Heng, Dong Jing-Ying, Zhao Ya-Nan, Wu Wen-Bing, Yang Xiao-Long, Chen Dan, Hu Kai-Feng, Chen Li-Hong, Liu Ji
Department of Biochemistry and Molecular Biology, West China School of Basic Medical Sciences and Forensic Medicine, Sichuan University, Chengdu 610041, China.
Sichuan Da Xue Xue Bao Yi Xue Ban. 2019 Mar;50(2):182-187.
To study the effect of methylation level of microRNA promoter on the expression of microRNAs (miRNA34a, miRNA34b, miRNA148a, miRNA203a) and on the proliferation, migration and invasion of lung cancer A549 cells.
The proliferation of A549 cells treated with different concentrations of demethylated drug 5-aza-2'-deoxycytidine (5-Aza-CdR) was measured by CCK8 assay and calculated the inhibitory rate in 24 h, 48 h and 72 h, respectively. After 72 h of treatment with 20 μmol/L 5-Aza-CdR, methylation-specific PCR (MSP) was used to detect the methylation level of A549 cells in miRNAs gene promoter regions, and real-time quantitative PCR (real-time PCR) was used to test the expression of miRNAs. The migration abilities of A549 cells treated with 20 μmol/L 5-Aza-CdR in 24 h and 48 h were performed with wound healing assay, while the invasion abilities in 48 h were evaluated by Transwell assay, respectively.
The proliferation inhibition rate of A549 cells gradually increased with the treatment concentration of 5-Aza-CdR increased and the treatment time prolonged. Compared with the control group, the methylated band of the experimental group was weaker and the unmethylated band was stronger, and the miRNAs gene promoter regions methylation level of the experimental group was lower than that of the control group. The expression level of miRNAs was significantly increased in the experimental group (<0.05) . The migration and invasion of the experimental group of A549 cells were inhibited compared with the control group (<0.05) .
5-Aza-CdR can reverse methylation levels of miRNAs promoter regions and upregulate the expression level of miRNA34a, miRNA34b, miRNA148a, miRNA203a, resulting in significantly inhibiting the proliferation, migration and invasion of lung cancer cells.
研究微小RNA启动子甲基化水平对微小RNA(miRNA34a、miRNA34b、miRNA148a、miRNA203a)表达以及对肺癌A549细胞增殖、迁移和侵袭的影响。
采用CCK8法检测不同浓度去甲基化药物5-氮杂-2'-脱氧胞苷(5-Aza-CdR)处理A549细胞后的增殖情况,分别计算24 h、48 h和72 h的抑制率。用20 μmol/L 5-Aza-CdR处理72 h后,采用甲基化特异性PCR(MSP)检测A549细胞miRNAs基因启动子区域的甲基化水平,采用实时定量PCR(实时PCR)检测miRNAs的表达。用伤口愈合实验检测20 μmol/L 5-Aza-CdR处理24 h和48 h的A549细胞的迁移能力,用Transwell实验分别评估48 h时的侵袭能力。
A549细胞的增殖抑制率随5-Aza-CdR处理浓度的增加和处理时间的延长而逐渐升高。与对照组相比,实验组甲基化条带较弱,非甲基化条带较强,实验组miRNAs基因启动子区域甲基化水平低于对照组。实验组miRNAs表达水平显著升高(<0.05)。与对照组相比,实验组A549细胞的迁移和侵袭受到抑制(<0.05)。
5-Aza-CdR可逆转miRNAs启动子区域的甲基化水平,上调miRNA34a、miRNA34b、miRNA148a、miRNA203a的表达水平,从而显著抑制肺癌细胞的增殖、迁移和侵袭。